{
    "title": "Individual feed for https://www.cnbc.com/id/15839135/device/rss/rss.html",
    "link": "https://www.cnbc.com/id/15839135/device/rss/rss.html",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-02-06T15:21:36.056688",
    "items": [
        {
            "title": "Shares of Peloton surge 9% as it edges toward profitability, posts better than expected sales",
            "link": "https://www.cnbc.com/2025/02/06/peloton-pton-q2-2025-earnings.html",
            "description": "Peloton has shifted its focus to boosting profitability at the expense of growing sales by cutting marketing and other administraitive costs.",
            "pubDate": "2025-02-06T20:09:38",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "Shares of Coach parent Tapestry spike, as holiday sales soar after merger collapse",
            "link": "https://www.cnbc.com/2025/02/06/tapestry-tpr-q2-2025-earnings.html",
            "description": "Coach's parent company reported the results less than two months after calling off its merger with fashion accessories competitor Capri.",
            "pubDate": "2025-02-06T19:01:39",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png"
        },
        {
            "title": "Roblox plummets 14% on disappointing bookings, daily active users miss",
            "link": "https://www.cnbc.com/2025/02/06/roblox-plummets-on-disappointing-bookings-daily-active-users-miss.html",
            "description": "Roblox shares plunged 14% after falling short of Wall Street's bookings and daily active user estimates.",
            "pubDate": "2025-02-06T18:50:46",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png"
        },
        {
            "title": "Eli Lilly has its mojo back ahead of a pivotal year for the obesity drug giant",
            "link": "https://www.cnbc.com/2025/02/06/eli-lilly-has-its-mojo-back-ahead-of-a-pivotal-year-for-the-drug-giant.html",
            "description": "The drugmaker is not perfect, as the past few months showed, but it's still a thoroughbred.",
            "pubDate": "2025-02-06T18:45:09",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Linde shares whipsaw after earnings, highlighting a crucial lesson for investors",
            "link": "https://www.cnbc.com/2025/02/06/linde-shares-whipsaw-after-earnings-highlighting-lesson-for-investors.html",
            "description": "Management assured us that its outlook is a starting point for the year and not hostage to currency fluctuations.",
            "pubDate": "2025-02-06T18:16:37",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        }
    ]
}